The allergy and immunology community mourns the loss of Marcus Maurer, MD, executive director of the Institute of Allergology ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved garadacimab (brand name Andembry) for patients aged 12 years and older with hereditary angioedema (HAE) to ...
The HAELO trial will assess the therapy’s safety and efficacy in 60 adult subjects with Type I or Type II HAE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback